Effects of oral administration of interferon-α on antibody production in mice with induced tolerance

Journal of Interferon and Cytokine Research

Volumn 19, Issue 8, 1999, Pages 895-900

  Takayama, Satoru ^a   Iwaki, Kanso ^a   Nishida, Yoshihiro ^a   Tanaka, Mari ^a   Fujii, Mitsukiyo ^a   Ohashi, Kunihiro ^a   Ikeda, Masao ^a   Kurimoto, Masashi ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON; MESSENGER RNA;

ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; GENE EXPRESSION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

2',5'-OLIGOADENYLATE SYNTHETASE; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; ANTIBODY FORMATION; DNA-BINDING PROTEINS; DRUG EVALUATION, PRECLINICAL; FEMALE; IMMUNE TOLERANCE; INTERFERON REGULATORY FACTOR-1; INTERFERON-ALPHA; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; PHOSPHOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ANIMALIA; MURINAE;

EID: 0032819074     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313424     Document Type: Article

References (13)

1. BROD, S.A., KERMAN. R.H., NELSON, L.D., MARSHALL, G.D., JR., HENNINGER, E.M., KHAN, M. JIN, R., and WOLIN- SKY, J.S. (1997). Ingested IFNα has biological effects in humans with relapsing-remitting multiple sclerosis. Multiple Sclerosis 3, 1-7.
2. BEILHARZ, M., McDONALD, W., WATSON, M.W., HENG, J., McGEACHIE, J., and LAWSON, C.M. (1997). Low-dose type I interferons reduce early virus replication of murine cytome- galovirus in vivo. J. Interferon Cytokine Res. 17, 625-530.
3. YOSHINO, S. (1995). The preventive effect of oral administration of type I Interferon on collagen-induced arthritis in rats. Exp. Mol. Pathol. 62, 123-130.
4. BROD, S.A., and KHAN, M. (1996). Oral administration of IFNα is superior to subcutaneous administration of IFNα in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J. Autoimmun. 9, 11-20.
5. FLEISCHMANN, R.W., JR., FIELDS, E.E., WANG, J.L., HUGHES, T.K., and STANTON, G.J. (1991). Modulation of peripheral leukocyte counts in mice by oral administration of interferons. Proc. Soc. Exp. Biol. Med. 197, 424-430.
6. NELSON, P.A., AKSELBAND, Y., DEARBORN, S.M., ALSABBAGH, A., JANE TIAN, Z., GONNELLA, P.A., ZAMVIL, S.S., CHEN, Y., and WEINER, H.L. (1997). Effect of oral beta interferon on subsequent immune responsiveness. In: The Oral Tolerance. H.L. Weiner and L.F. Mayer (ed.) (1996). Ann. New York Acad. Sci. 778, 145-155.
7. SPERBER, S.J., GOCKE, D.J., HABERZETTL, C.A., and PESTKA, S. (1993). Low-dose oral recombinant interferon-α A in patients with HIV-1 infection: a blinded pilot. AIDS 7, 693-697.
8. INOUE, K., SUGIYAMA, H., and KISHIMOTO, T. (1994). Expression of the Interleukin 6 (IL-6), IL-6 receptor, and gp130 genes in acute leukemia. Blood 84, 2672-2680.
9. BECKER, S., QUAY, J., and SOUKUP, J. (1991). Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 147, 4307-4312.
10. MIYMOTO, M., FUJITA, T., and TAIGUCHI, T. (1988). Regulated expression of a gene encoding a nuclear factor. IRF-1, that specifically binds to IFNβ gene regulatory elements. Cell 54, 903-913.
11. SOKAWA, Y., KITANO, Y., and TAKEDA, K. (1994). Physiological expression of 2′,5′-oligoadenylate synthetase gene in mouse intestine. J. Interferon Res. 14, 121-127.
12. MERRITT, J.A., BORDEN, E.G., and BALL, L.A. (1985). Measurement of 2′,5′-oligoadenylate synthetase in patients receiving interferon alpha. J. Interferon Res. 5, 191-198.
13. COHEN, B., PERETZ, D., and CHEBATH, J. (1988). Enhancer-like interferon responsive sequences of the human and mouse (2′- 5′) oligoadenylate synthetase gene promoters. EMBO J. 7, 1411-1419.